May 15 (Reuters) - About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with ...

Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new ...

NEW ALBANY, Ohio — Biotechnology company Amgen announced a $900 million expansion of its New Albany facility on Friday. The expansion will add 350 new jobs in central Ohio. Several leaders spoke at an ...

The latest fair value estimate for Amgen has shifted slightly, from US$350.03 to US$349.66, keeping modeled upside closely ...

Feb 3 (Reuters) - Amgen on Tuesday reported fourth-quarter financial ‌results that came in ahead of Wall Street ‌expectations, sending its shares modestly higher as the company continues to express ...

If you are wondering whether Amgen’s current share price reflects its true worth, starting with a clear look at what the ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

Amgen announced 52-week results from a phase 2 trial with its weight-management candidate, MariTide. The results Amgen posted don't appear very competitive with Eli Lilly's weight management drug, ...

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public. | A quantum ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN | AMGN Price Prediction) to $340 from $351 on Monday, May 4, ...

About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease ...